Literature DB >> 25478942

Mesenchymal stem cell therapy for acute respiratory distress syndrome: a light at the end of the tunnel?

Jae-Woo Lee1, Patricia R M Rocco, Paolo Pelosi.   

Abstract

Entities:  

Mesh：

Year:  2015        PMID： 25478942      PMCID： PMC4301977          DOI： 10.1097/ALN.0000000000000546

Source DB:  PubMed          Journal:  Anesthesiology        ISSN： 0003-3022            Impact factor:   7.892


× No keyword cloud information.
  19 in total

1.  Comparison of two fluid-management strategies in acute lung injury.

Authors:  Herbert P Wiedemann; Arthur P Wheeler; Gordon R Bernard; B Taylor Thompson; Douglas Hayden; Ben deBoisblanc; Alfred F Connors; R Duncan Hite; Andrea L Harabin
Journal:  N Engl J Med       Date:  2006-05-21       Impact factor: 91.245

2.  Bone marrow mononuclear cell therapy led to alveolar-capillary membrane repair, improving lung mechanics in endotoxin-induced acute lung injury.

Authors:  Luiz Felipe M Prota; Roberta M Lassance; Tatiana Maron-Gutierrez; Raquel C Castiglione; Cristiane Souza Baez Garcia; Maria Cristina Ebole Santana; Jackson Souza-Menezes; Soraia C Abreu; Vivian Samoto; Marcelo Felipe Santiago; Vera Luiza Capelozzi; Christina Maeda Takiya; Patricia R M Rocco; Marcelo M Morales
Journal:  Cell Transplant       Date:  2010-05-04       Impact factor: 4.064

3.  Mesenchymal stem cells enhance recovery and repair following ventilator-induced lung injury in the rat.

Authors:  Gerard F Curley; Mairead Hayes; Bilal Ansari; Georgina Shaw; Aideen Ryan; Frank Barry; Timothy O'Brien; Daniel O'Toole; John G Laffey
Journal:  Thorax       Date:  2011-11-21       Impact factor: 9.139

4.  Ventilation with lower tidal volumes as compared with traditional tidal volumes for acute lung injury and the acute respiratory distress syndrome.

Authors:  Roy G Brower; Michael A Matthay; Alan Morris; David Schoenfeld; B Taylor Thompson; Arthur Wheeler
Journal:  N Engl J Med       Date:  2000-05-04       Impact factor: 91.245

5.  Bone marrow-derived mononuclear cell therapy in experimental pulmonary and extrapulmonary acute lung injury.

Authors:  Indianara M Araújo; Soraia C Abreu; Tatiana Maron-Gutierrez; Fernanda Cruz; Livia Fujisaki; Humberto Carreira; Felipe Ornellas; Debora Ornellas; Adriana Vieira-de-Abreu; Hugo C Castro-Faria-Neto; Alexandre Muxfeldt Ab'Saber; Walcy R Teodoro; Bruno L Diaz; Carlos Peres Dacosta; Vera L Capelozzi; Paolo Pelosi; Marcelo M Morales; Patricia R M Rocco
Journal:  Crit Care Med       Date:  2010-08       Impact factor: 7.598

6.  Mesenchymal stem cells reduce inflammation while enhancing bacterial clearance and improving survival in sepsis.

Authors:  Shirley H J Mei; Jack J Haitsma; Claudia C Dos Santos; Yupu Deng; Patrick F H Lai; Arthur S Slutsky; W Conrad Liles; Duncan J Stewart
Journal:  Am J Respir Crit Care Med       Date:  2010-06-17       Impact factor: 21.405

7.  Mesenchymal stem cells enhance survival and bacterial clearance in murine Escherichia coli pneumonia.

Authors:  Naveen Gupta; Anna Krasnodembskaya; Maria Kapetanaki; Majd Mouded; Xinping Tan; Vladimir Serikov; Michael A Matthay
Journal:  Thorax       Date:  2012-01-16       Impact factor: 9.139

8.  Incidence and outcomes of acute lung injury.

Authors:  Gordon D Rubenfeld; Ellen Caldwell; Eve Peabody; Jim Weaver; Diane P Martin; Margaret Neff; Eric J Stern; Leonard D Hudson
Journal:  N Engl J Med       Date:  2005-10-20       Impact factor: 91.245

9.  Bone marrow stromal cells attenuate sepsis via prostaglandin E(2)-dependent reprogramming of host macrophages to increase their interleukin-10 production.

Authors:  Krisztián Németh; Asada Leelahavanichkul; Peter S T Yuen; Balázs Mayer; Alissa Parmelee; Kent Doi; Pamela G Robey; Kantima Leelahavanichkul; Beverly H Koller; Jared M Brown; Xuzhen Hu; Ivett Jelinek; Robert A Star; Eva Mezey
Journal:  Nat Med       Date:  2008-11-21       Impact factor: 53.440

10.  Cryopreserved mesenchymal stromal cells display impaired immunosuppressive properties as a result of heat-shock response and impaired interferon-γ licensing.

Authors:  Moïra François; Ian B Copland; Shala Yuan; Raphaëlle Romieu-Mourez; Edmund K Waller; Jacques Galipeau
Journal:  Cytotherapy       Date:  2011-10-27       Impact factor: 5.414
View more
  6 in total

Review 1.  Emerging therapies for the prevention of acute respiratory distress syndrome.

Authors:  Carl A Ruthman; Emir Festic
Journal:  Ther Adv Respir Dis       Date:  2015-05-22       Impact factor: 4.031

Review 2.  Mesenchymal stem cell-derived extracellular vesicles for kidney repair: current status and looming challenges.

Authors:  Arash Aghajani Nargesi; Lilach O Lerman; Alfonso Eirin
Journal:  Stem Cell Res Ther       Date:  2017-12-04       Impact factor: 6.832

Review 3.  Pathophysiology and potential future therapeutic targets using preclinical models of COVID-19.

Authors:  Rahul Kumar; Michael H Lee; Claudia Mickael; Biruk Kassa; Qadar Pasha; Rubin Tuder; Brian Graham
Journal:  ERJ Open Res       Date:  2020-12-07

Review 4.  Molecular Mechanisms of Mesenchymal Stem Cell-Based Therapy in Acute Kidney Injury.

Authors:  Pei-Wen Lee; Bo-Sheng Wu; Chih-Yu Yang; Oscar Kuang-Sheng Lee
Journal:  Int J Mol Sci       Date:  2021-10-22       Impact factor: 5.923

5.  Therapeutic Delivery Specifications Identified Through Compartmental Analysis of a Mesenchymal Stromal Cell-Immune Reaction.

Authors:  Matthew Li; Danika Khong; Ling-Yee Chin; Amy Singleton; Biju Parekkadan
Journal:  Sci Rep       Date:  2018-05-01       Impact factor: 4.379

6.  Mesenchymal Stromal Cells in Pediatric Hematopoietic Cell Transplantation a Review and a Pilot Study in Children Treated With Decidua Stromal Cells for Acute Graft-versus-Host Disease.

Authors:  Olle Ringdén; Britt Gustafsson; Behnam Sadeghi
Journal:  Front Immunol       Date:  2020-10-19       Impact factor: 7.561
  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.